Elsevier

Chemistry and Physics of Lipids

Volume 45, Issues 2–4, November–December 1987, Pages 143-169
Chemistry and Physics of Lipids

Glutathione depleting agents and lipid peroxidation

https://doi.org/10.1016/0009-3084(87)90064-8Get rights and content

Abstract

The mechanisms by which glutathione (GSH) depleting agents produce cellular injury, particularly liver cell injury have been reviewed. Among the model molecules most thoroughly investigated are bromobenzene and acetaminophen. The metabolism of these compounds leads to the formation of electrophilic reactants that easily conjugate with GSH. After substantial depletion of GSH, covalent binding of reactive metabolites to cellular macromolecules occurs. When the hepatic GSH depletion reaches a threshold level, lipid peroxidation develops and severe cellular damage is produced. According to experimental evidence, the cell death seems to be more strictly related to lipid peroxidation rather than to covalent binding. Loss of protein sulfhydryl groups may be an important factor in the disturbance of calcium homeostasis which, according to several authors, leads to irreversible cell injury. In the bromobenzene-induced liver injury loss of protein thiols as well as impairment of mitochondrial and microsomal Ca2+sequestration activities are related to lipid peroxidation. However, some redox active compounds such as menadione and t-butylhydroperoxide produce direct oxidation of protein thiols.

References (178)

  • P.N. Magee et al.

    Adv. Cancer Res.

    (1967)
  • J.R. Mitchell et al.

    Gastroenterology

    (1975)
  • J.R. Gillette

    Biochem. Pharmacol.

    (1974)
  • L.F. Prescott et al.

    Lancet

    (1971)
  • T.R. Tephly et al.

    Biochem. Biophys. Res. Commun.

    (1971)
  • J.A. Hinson et al.

    Life Sci.

    (1981)
  • D. Labadarios et al.

    Biochem. Pharmacol.

    (1977)
  • J.G. Gerber et al.

    Lancet

    (1977)
  • J.L. Devalia et al.

    Biochem. Pharmacol.

    (1982)
  • A.E.M. McLean et al.

    Biochem. Pharmacol.

    (1978)
  • H. Thor et al.

    Arch. Biochem. Biophys.

    (1978)
  • H. Thor et al.

    Arch. Biochem. Biophys.

    (1978)
  • R.A. Wiley et al.

    Toxicol. Appl. Pharamcol.

    (1979)
  • E.L. Docks et al.

    Biochem. Pharmacol.

    (1975)
  • J.R. Gillette

    Biochem. Pharmacol.

    (1974)
  • G.C. Mills

    J. Biol. Chem.

    (1957)
  • C. Little et al.

    Biochem. Biophys. Res. Commun.

    (1968)
  • B.O. Christophersen

    Biochim. Biophys. Acta

    (1969)
  • C. Little et al.

    J. Biol. Chem.

    (1970)
  • L. Flohé et al.

    FEBS Lett.

    (1973)
  • F. Ursini et al.

    Biochim. Biophys. Acta

    (1982)
  • F. Ursini et al.

    Biochim. Biophys. Acta

    (1985)
  • R.A. Lawrence et al.

    Biochem. Biophys. Res. Commun.

    (1976)
  • R.F. Burk et al.

    J. Biol. Chem.

    (1978)
  • M. Younes et al.

    Chem. Biol. Interact.

    (1981)
  • A. Wendel et al.

    Biochem. Pharmacol.

    (1979)
  • E. Albano et al.

    Chem.-Biol. Interact.

    (1983)
  • A. Casini et al.

    J. Biol. Chem.

    (1982)
  • A. Wendel et al.

    Biochem. Pharmacol.

    (1981)
  • A. Benedetti et al.

    Biochim. Biophys. Acta

    (1982)
  • R.J. Gerson et al.

    Biochem. Biophys. Res. Commun.

    (1985)
  • W.M. Kluwe et al.

    Biochem. Pharmacol.

    (1981)
  • E. Nachtomi et al.

    Exp. Mol. Pathol.

    (1972)
  • E. Albano et al.

    Chem.-Biol. Interact.

    (1984)
  • P.M. Vignais et al.

    Biochim. Biophys. Acta

    (1973)
  • P.C. Jocelyn et al.

    Biochim. Biophys. Acta

    (1974)
  • P.C. Jocelyn

    Biochim. Biophys. Acta

    (1975)
  • A. Wahlländer et al.

    FEBS Lett.

    (1979)
  • M.J. Meredith et al.

    J. Biol. Chem.

    (1982)
  • M.J. Meredith et al.

    Biochem. Pharmacol.

    (1983)
  • J.R. Babson et al.

    Biochem. Biophys. Res. Commun.

    (1978)
  • J.R. Babson et al.

    Biochem. Pharmacol.

    (1981)
  • G.M. Rosen et al.

    Biochem. Pharmacol.

    (1983)
  • R. Reiter et al.

    Biochem. Pharmacol.

    (1983)
  • V. Fischer et al.

    J. Biol. Chem.

    (1985)
  • A.G. Hildebrandt et al.

    Biochem. Biophys. Res. Commun.

    (1973)
  • A.G. Hildebrandt et al.

    Arch. Biochem. Biophys.

    (1975)
  • G.D. Nordblom et al.

    Arch. Biochem. Biophys.

    (1977)
  • H.W. Strobel et al.

    J. Biol. Chem.

    (1971)
  • C. Richter et al.

    J. Biol. Chem.

    (1977)
  • Cited by (154)

    • Dietary fenugreek (Trigonella foenum-graecum) seeds and garlic (Allium sativum) alleviates oxidative stress in experimental myocardial infarction

      2017, Food Science and Human Wellness
      Citation Excerpt :

      Glutathione plays an important role in the regulation of various cell functions and in cell protection from oxidative injury. Depletion of glutathione results in enhanced lipid peroxidation and excessive lipid peroxidation cause increased glutathione consumption [41] as observed in the present study. Garlic pretreated isoproterenol administered rats are reported to have maintained the level of lipid peroxides to near normal when compared to un-pretreated controls.

    • Narirutin fraction from citrus peels attenuates alcoholic liver disease in mice

      2013, Food and Chemical Toxicology
      Citation Excerpt :

      Therefore, the maintaining of these antioxidant systems is not only important for suppressing fatty liver but also suppressing further damage to hepatocytes that is caused by lipid peroxidation. Many reports have described that lipid peroxidation of hepatic tissues caused by ROS is the main cause of liver damage induced by ethanol and can produce harmful radicals (Albano, 2006; Comporti, 1987; Lieber, 1997; Nordmann et al., 1990). Tuma et al. have also demonstrated that rat liver produced large amounts of MDA and acetaldehyde after ethanol administration (Tuma et al., 1996).

    View all citing articles on Scopus
    View full text